Re: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 01期
关键词：
D O I：
10.1097/JU.0000000000001450
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：303 / 304
页数：2
相关论文
共 50 条
  • [31] Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer
    Gupta, Dipti
    Chuy, Katherine Lee
    Yang, Ji Can
    Bates, Megan
    Lombardo, Marissa
    Steingart, Richard M.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (10) : 580 - +
  • [32] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer REPLY
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 580 - 580
  • [33] Re: Effectiveness of Primary Androgen-Deprivation Therapy for Clinically Localized Prostate Cancer Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2014, 192 (05): : 1422 - 1422
  • [34] ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: DETAILED SAFETY ANALYSIS FROM THE RANDOMIZED PHASE 3 HERO STUDY
    Mehlhaff, Bryan
    Shore, Neal D.
    George, Daniel J.
    Cookson, Michael S.
    Saltzstein, Daniel R.
    Tutrone, Ronald
    Bailen, James L.
    Brown, Bruce
    Langenberg, Andria G. M.
    Fallick, Mark
    Lu, Sophia
    Hanson, Sarah
    Tombal, Bertrand
    Saad, Fred
    JOURNAL OF UROLOGY, 2022, 207 (05): : E456 - E456
  • [35] Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer
    Alberga, Angela S.
    Segal, Roanne J.
    Reid, Robert D.
    Scott, Chris G.
    Sigal, Ronald J.
    Khandwala, Farah
    Jaffey, James
    Wells, George A.
    Kenny, Glen P.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 971 - 981
  • [36] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    C Jin
    Y Fan
    Y Meng
    C Shen
    Y Wang
    S Hu
    C Cui
    T Xu
    W Yu
    J Jin
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 333 - 339
  • [37] Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
    Niraula, Saroj
    Tannock, Ian F.
    JAMA ONCOLOGY, 2016, 2 (04) : 461 - 462
  • [38] Immediate versus deferred androgen-deprivation therapy for localized prostate cancer
    Nature Clinical Practice Urology, 2006, 3 (7): : 348 - 349
  • [39] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Roe, Kathrine
    Mikalsen, Lars T. G.
    van der Kogel, Albert J.
    Bussink, Johan
    Lyng, Heidi
    Ree, Anne H.
    Marignol, Laure
    Olsen, Dag R.
    RADIATION ONCOLOGY, 2012, 7
  • [40] Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
    Cattrini, Carlo
    Zanardi, Elisa
    Boccardo, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2350 - +
12345